Aurora Spine Corporation has announced the launch of its new division, Aurora Biologics, aimed at improving spinal fusion success through innovative biologic solutions. This initiative was revealed on October 27, 2025, in Carlsbad, California.
The establishment of Aurora Biologics represents a strategic effort to enhance the synergy within Aurora”s comprehensive spine ecosystem. This ecosystem includes well-known interspinous, lumbar, and sacroiliac fusion systems, featuring products like ZIP, Hydra A.E.R.O., DEXA, and SiLO. By integrating mechanical and regenerative technologies into one cohesive platform, the new division aims to significantly improve patient outcomes and surgical efficiency.
With Aurora Biologics, the company is positioning itself to lead advancements in spinal health, focusing on fostering long-term fusion integrity. This launch aligns with Aurora Spine”s commitment to providing minimally invasive solutions and enhancing the overall quality of care in spinal and interventional pain management.
As the field of spinal surgery evolves, Aurora Biologics is poised to make a substantial impact by delivering cutting-edge biologic innovations that support successful surgical interventions. This initiative underscores Aurora Spine”s dedication to pioneering solutions that meet the growing demands of the medical community and improve patient recovery and satisfaction.
